Mammaglobin 1: not only a breast-specific and tumour-specific marker, but also a hormone-responsive endometrial protein
| Autor: | Joachim Alfer, Katrin Gröting, Henning M. Beier, Claudia A. Krusche, Sabine Moss, Irmgard Classen-Linke |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Histology biology business.industry media_common.quotation_subject Endometriosis General Medicine Luteal phase medicine.disease Promegestone Pathology and Forensic Medicine Reverse transcription polymerase chain reaction chemistry.chemical_compound Endocrinology Mammaglobin Breast cancer chemistry Internal medicine biology.protein Cancer research Medicine Immunohistochemistry business Menstrual cycle media_common |
| Zdroj: | Histopathology. 61:955-965 |
| ISSN: | 0309-0167 |
| DOI: | 10.1111/j.1365-2559.2012.04290.x |
| Popis: | Classen-Linke I, Moss S, Groting K, Beier H M, Alfer J & Krusche C A (2012) Histopathology 61, 955–965 Mammaglobin 1: not only a breast-specific and tumour-specific marker, but also a hormone-responsive endometrial protein Aims: The secretoglobin mammaglobin 1 (MGB1) is strongly expressed in breast tumours, and is therefore used to detect breast cancer metastases, although it has also been detected in other tissues. The aim of this study was to examine MGB1 expression and its hormonal regulation in human endometrium to further investigate the use of MGB1 as a marker molecule. Methods and results: Mammaglobin 1 expression was assessed immunohistochemically in endometrial samples from 60 normal fertile patients throughout the menstrual cycle, in 49 endometriotic tissue samples, in 15 endometrial adenocarcinomas, and in 36 breast carcinomas. In addition, 25 endometrial samples were analysed by western blot and quantitative real-time reverse transcription polymerase chain reaction. To prove hormonal regulation, primary endometrial epithelial cells were cultured with 17β-oestradiol and promegestone. MGB1 was detected in human endometrial tissue, with peak expression during the luteal phase, in 31% of endometriotic samples, in 53% of endometrial adenocarcinomas, and in 64% of breast carcinomas. MGB1 mRNA expression was increased in vitro by hormonal treatment. Conclusions: Our data show that MGB1 expression is not restricted to normal and malignant breast tissue. Besides its documented occurrence in endometriotic and malignant endometrial tissues, MGB1 is also expressed in normal human endometrium, and such expression is controlled by steroid hormones. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|